Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.

BACKGROUND The diagnostic value of circulating mRNA for the early detection of primary and recurrent gastric cancer was evaluated. PATIENTS AND METHODS Circulating hTERT and MUC1 mRNA were amplified in the plasma from 52 gastric cancer patients (40 preoperative and 12 postoperative patients) and 20 healthy controls. The results were compared with those of a circulating cancer cell assay and methylation-specific polymerase chain reaction assay. RESULTS Cell-free mRNA of the analyzed genes was detected in 6 (15%) preoperative gastric cancer patients (hTERT: 3 and MUC1: 4 patients) and 2 follow-up patients. These mRNAs were not detected in the plasma from healthy volunteers. There was no correlation between the results of the cell-free mRNA and the other assays. CONCLUSION Detection of circulating cell-free mRNA might serve as a new complementary tumor marker for gastric cancer.

[1]  D. Pectasides,et al.  CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma. , 1997, American journal of clinical oncology.

[2]  D. Ichikawa,et al.  Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer. , 2004, Anticancer research.

[3]  Y. Lo,et al.  Stability of endogenous and added RNA in blood specimens, serum, and plasma. , 2002, Clinical chemistry.

[4]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[5]  D. Ichikawa,et al.  Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer. , 2000, Anticancer research.

[6]  K. Ohuchida,et al.  Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer , 2006, International journal of cancer.

[7]  Keiichi Maruyama,et al.  Progress in gastric cancer surgery in Japan and its limits of radicality , 1987, World Journal of Surgery.

[8]  N. Miura,et al.  Serum Human Telomerase Reverse Transcriptase Messenger RNA as a Novel Tumor Marker for Hepatocellular Carcinoma , 2005, Clinical Cancer Research.

[9]  D. Ichikawa,et al.  Comparison of methylation‐specific polymerase chain reaction (MSP) with reverse transcriptase‐polymerase chain reaction (RT‐PCR) in peripheral blood of gastric cancer patients , 2004, Journal of surgical oncology.

[10]  G. Sorenson,et al.  Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  F. Chan,et al.  Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer , 2005, British Journal of Cancer.

[12]  Li-hua Hu,et al.  Real-time determination of human telomerase reverse transcriptase mRNA in gastric cancer. , 2004, World journal of gastroenterology.

[13]  Hirofumi Nakayama,et al.  Molecular-pathological prognostic factors of gastric cancer: a review , 2005, Gastric Cancer.

[14]  F. Roviello,et al.  Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. , 2001, American journal of surgery.

[15]  Jaw-Yuan Wang,et al.  Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[16]  S. Natsugoe,et al.  Clinical Importance of Preoperative Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 Levels in Gastric Cancer , 2001, Journal of clinical gastroenterology.

[17]  B. Shapiro,et al.  Free DNA in the serum of cancer patients and the effect of therapy. , 1977, Cancer research.

[18]  S. Burchill,et al.  The molecular detection of circulating tumour cells. , 1995, British Journal of Cancer.

[19]  P. Johnson,et al.  Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. , 2002, Clinical chemistry.

[20]  N. Miura,et al.  Sensitive Detection of Human Telomerase Reverse Transcriptase mRNA in the Serum of Patients with Hepatocellular Carcinoma , 2003, Oncology.

[21]  T. Godfrey,et al.  Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. , 2005, Clinical chemistry.